This opens the possibility that (early) interventions able to normalize/reduce plasma insulin concentrations might play a key role in the prevention and treatment of obesity, type 2 diabetes, cardiovascular disease, cancer and premature mortality [10,17]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.